Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Triamcinolone Acetonide as an Adjunctive to VPDT in ARMD.
This study is ongoing, but not recruiting participants.
Study NCT00148551. Last updated on July 26, 2007.
Information provided by Canadian Retinal Trials Group
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Age-Related Macular Degeneration
Additional conditions recognized in this trial
Macular Degeneration
More general conditions related to this trial
Eye Diseases
Retinal Degeneration
Retinal Diseases
Interventions listed in this trial
Triamcinolone Acetonide
Additional drug interventions recognized in this trial
Triamcinolone
Triamcinolone diacetate
Triamcinolone hexacetonide
More general drug interventions related to this trial
Anti-Inflammatory Agents
Enzyme Inhibitors
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Canadian Retinal Trials Group
University of British Columbia
QLT Inc
Vancouver Hospital
Back to top of Main Content